Inactive Instrument

Insiders Roche Holding AG Xetra

Equities

Roche Expects Sales, Core Earnings Growth -- Update	02-01	DJ
Roche Expects Sales, Core Earnings Growth	02-01	DJ
Roche Named Third Most Sustainable Company on Dow Jones' Pharmaceuticals Index	12-15	MT
Bayer's new CEO plans to cut management jobs in prelude to overhaul	23-09-15	RE
Bayer's new CEO plans to cut management jobs in prelude to overhaul	23-09-14	RE
Destiny Pharma picks interim CEO as Clark makes quick exit	23-05-25	AN
Roche Q1 sales down 7% as COVID-related business wanes	23-04-26	RE
Roche Holding AG Approves Board and Board Committee Changes	23-03-14	CI
Johnson & Johnson names ex-Sanofi executive as pharma, R&D vice president	23-02-13	RE
Bayer's new CEO: long-time Roche, Genentech executive, Bill Anderson	23-02-08	RE
Bayer Taps Roche's Bill Anderson as New CEO; Succession Due in Coming Months	23-02-08	DJ
Bayer picks outsider Anderson as CEO after investor pressure	23-02-08	RE
Bayer Appoints Former Roche Executive as CEO	23-02-08	MT
Roche Names CEO for Pharmaceuticals Unit	23-02-02	MT
Roche flags 2023 earnings decline on slump in COVID products	23-02-02	RE
Roche Holding AG Announces Executive Appointments	23-02-02	CI
Roche Seeks Internal Candidate To Succeed Pharmaceutical Unit's CEO	23-01-11	MT
Swiss Drugmaker Roche CEO To Take Over As Chairman In 2023	22-12-12	MT
Roche Holding Ag Announces Executive Changes	22-12-12	CI
Roche Diagnostics North America Announces Brad Moore as President, Effective January 1, 2023	22-12-05	CI

No results for this search

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am